Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | CES1 | P23141 | 2/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL728757 | 0.95 | ALDH1A1 (0.66) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL7596117 | 0.88 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL12501661 | 0.88 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL11689544 | 0.88 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL28815673 | 0.88 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL30917331 | 0.88 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL8590575 | 0.87 | ALDH1A1 (0.90) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL9798039 | 0.86 | CYP3A4 (0.75) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL3968747 | 0.86 | TSHR (0.61) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 | |
| SCHEMBL1928079 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TSHRCYP3A4SMN1; SMN2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1734 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008743-A1 | PROCESS FOR PRODUCING POLYUNSATURATED FATTY ACIDS IN THE FORM OF ESTERS | ENI S.P.A. (IT) | 2026-01-08 | — | — | US | claimed |
| US-20250304688-A1 | Methods and Compositions Comprising Anti-CD3 Antibodies and DYRK1A Inhibitors for Treating Diabetes | PROVENTION BIO, INC. (US) | 2025-10-02 | — | — | US | claimed |
| EP-4555055-A1 | PROCESS FOR PRODUCING POLYUNSATURATED FATTY ACIDS IN THE FORM OF ESTERS | Eni S.p.A. (IT) | 2025-05-21 | — | — | EP | claimed |
| CN-119752357-A | Low-VOC gas volatilization high-temperature-resistant hot melt adhesive composite film and preparation method thereof | 江苏惠沣环保科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119177000-B | Salt-fog-resistant epoxy modified aqueous acrylic resin emulsion and preparation method and application thereof | 台昌树脂(佛山)有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119546736-A | Method for producing polyunsaturated fatty acids in the form of esters | 艾尼股份公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119492837-A | Method for detecting N-methyl-D-prolinol isomer | 江苏恒瑞医药股份有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119431208-A | Method for preparing vitamin D2 with high conversion rate and high selectivity | 成都亚中生物制药有限责任公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119217618-A | Preparation method of interlayer crosslinked polyimide three-layer composite film | 沙洲职业工学院 | 2024-12-31 | — | — | CN | claimed |
| CN-119177000-A | Salt-fog-resistant epoxy modified aqueous acrylic resin emulsion and preparation method and application thereof | 台昌树脂(佛山)有限公司 | 2024-12-24 | — | — | CN | claimed |
| WO-1989008835-A1 | THIOACYLATION PEPTIDE SEQUENCING WITH ACYLATION OF THIAZOLINES | BIO-AFFINITY SYSTEMS, INC. (US) | 1989-09-21 | — | — | WO | claimed |
| US-4861726-A | Method of thioacylation peptide sequencing with acylation of thiazoloinones | BIO-AFFINITY SYSTEMS, INC. (US) | 1989-08-29 | — | — | US | claimed |
| EP-0206283-A2 | Optically active pyridobenzoxazine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1986-12-30 | — | — | EP | claimed |
| EP-0008599-B1 | SURFACTANT AND PHENOLIC FOAM PRODUCED THEREWITH | Celotex Corporation (US) | 1983-12-14 | — | — | EP | claimed |
| US-4205135-A | COMPRISING PHENOLIC RESIN POLYMER AND A SURFACTANT WHICH IS NONIONIC, BRANCHED, AND HAS HYDROXYL VLAUE LESS THAN 50 | THE CELOTEX CORPORATION (US) | 1980-05-27 | — | — | US | claimed |
| EP-0008599-A1 | SURFACTANT AND PHENOLIC FOAM PRODUCED THEREWITH. | CELOTEX CORP (US) | 1980-03-19 | — | — | EP | claimed |
| WO-1979000163-A1 | PHENOLIC FOAM AND SURFACTANT USEFUL THEREIN | CELOTEX CORP (US) | 1979-04-05 | — | — | WO | claimed |
| US-4142853-A | BENZOYLATION | SHIKIBO LIMITED (JP) | 1979-03-06 | — | — | US | claimed |
| US-4140842-A | ENCAPPED REACTION PRODUCT OF A POLYOXYALKYLATED DIAMINE AND A COPOLYMER OF DIALKYL MALEATE AND A CYCLIC VINYL AMIDE | THE CELOTEX CORPORATION (US) | 1979-02-20 | — | — | US | claimed |
| US-4088483-A | SELENIUM, POLYVINYLCARBAZOLE, NITRATED BENZOIC ACID DERIVATIVE | MINOLTA CAMERA KABUSHIKI KAISHA (JA) | 1978-05-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008743-A1 | PROCESS FOR PRODUCING POLYUNSATURATED FATTY ACIDS IN THE FORM OF ESTERS | ELOVL1, ELOVL6, ELOVL3 | ALDH1A1 952/4885TSHR 1060/4885CYP3A4 2013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.